In October 2019 CytaCoat raised €460 k (SEK 5 million) in an oversubscribed New Issue. The funds will be used to continue the prototype development of coated medical devices and commercialization of the CytaCoat technology. It will also allow CytaCoat to make key appointments to the executive team.